CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS

The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and methods of using such cells to treat cancers that express or overexpress the Glypican 2 antigen.

Saved in:
Bibliographic Details
Main Authors BARRETT, David, MACKALL, Crystal, JELEV, Dontcho V, HEITZENEDER, Sabine, MARIS, John, BOSSE, Kristopher, FOSTER, Jessica, DIMITROV, Dimiter, MAJZNER, Robbie, ZHU, ZHONGYU
Format Patent
LanguageEnglish
Published 18.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and methods of using such cells to treat cancers that express or overexpress the Glypican 2 antigen.
AbstractList The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and methods of using such cells to treat cancers that express or overexpress the Glypican 2 antigen.
Author DIMITROV, Dimiter
MARIS, John
ZHU, ZHONGYU
FOSTER, Jessica
BARRETT, David
HEITZENEDER, Sabine
JELEV, Dontcho V
MACKALL, Crystal
BOSSE, Kristopher
MAJZNER, Robbie
Author_xml – fullname: BARRETT, David
– fullname: MACKALL, Crystal
– fullname: JELEV, Dontcho V
– fullname: HEITZENEDER, Sabine
– fullname: MARIS, John
– fullname: BOSSE, Kristopher
– fullname: FOSTER, Jessica
– fullname: DIMITROV, Dimiter
– fullname: MAJZNER, Robbie
– fullname: ZHU, ZHONGYU
BookMark eNrjYmDJy89L5WRwcPbw9HUN8nRWcPQL8XR39VMIcnV2DQjxDwpWcPb3C3H09PP0c1dw94kM8HR29FMwUnDy9HMBCbn4-wIlg3kYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSXxosJGBkZGRqbmZqbGjoTFxqgBj4i03
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2022257653A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2022257653A13
IEDL.DBID EVB
IngestDate Fri Aug 30 05:42:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2022257653A13
Notes Application Number: US202017597580
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&CC=US&NR=2022257653A1
ParticipantIDs epo_espacenet_US2022257653A1
PublicationCentury 2000
PublicationDate 20220818
PublicationDateYYYYMMDD 2022-08-18
PublicationDate_xml – month: 08
  year: 2022
  text: 20220818
  day: 18
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
The Children's Hospital of Philadelphia
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC
RelatedCompanies_xml – name: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVIC
– name: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
– name: The Children's Hospital of Philadelphia
Score 3.413474
Snippet The present disclosure is directed to chimeric antigen receptors binding to Glypican 2, nucleic acids encoding the same, and cells expressing the same, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title CHIMERIC ANTIGEN RECEPTORS CONTAINING GLYPICAN 2 BINDING DOMAINS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220818&DB=EPODOC&locale=&CC=US&NR=2022257653A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpW5F2bdkeirZptlVcWvoh82n0ayBIN1zFf99L2HRPe0tyEC4hl_tI7ncADyj-ulaZuZpbWqkaaJSq6AZleJZRPZt5ZmSF_G3BrUlqvMzMWQs-t7kwEif0R4IjokQVKO-NvK9X_0EsT_6tXD_mHzi0fBoltqdsvGNdFwhtiufaLAy8gCqU2mms8EjShG1t9h30lQ6EIS2Q9tmbK_JSVrtKZXQKhyHOVzdn0KrqDhzTbe21DhxNN0_e2NxI3_ocnunEl0UaicMTf8w4iRhlYRJEMaEBTxyf-3xMxq_voSjkSHTi-twTQ14wRWJ8AfcjltCJiqzM_1Y-T-NdvvuX0K6XdXUFpEBHxOyLNFFrYWhZORQ4WkOrNPJqMdCKrAu9fTNd7yffwInoitCpNuhBu_n6rm5R9zb5ndyyX9glgJ0
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb0XatXV7GLqln7qlpR8yn0rbdSBIN1zFf99L2HRPewt3EJKQy33k7ncA9yj-qlLquZwbykzW0CiV0Q3K8C6jetbzTMsKkW3BDDfRXqb6tAGfm1oYgRP6I8ARUaIKlPdavNfL_yCWKXIrVw_5B5IWT3Y8MKW1d6yqHKFNMkcDK_BNn0qUDpJIYqHgcdta7w7RV9p75Pi83Hh6G_G6lOW2UrGPYD_A-ar6GBpl1YYW3fRea8PBZP3ljcO19K1O4Jm6nmjSSIYs9hyLkdCiVhD7YUSoz-KhxzzmEGf8HvBGjkQlI4-ZnGT6E2RGp3BnWzF1ZVxK-rfzNIm21909g2a1qMpzIAU6InqXl4kac03JZn2Oo9U3ZlpezntKkV1AZ9dMl7vZt9By48k4HXvs9QoOOYuHUZVeB5r113d5jXq4zm_E8f0CBESDig
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CHIMERIC+ANTIGEN+RECEPTORS+CONTAINING+GLYPICAN+2+BINDING+DOMAINS&rft.inventor=BARRETT%2C+David&rft.inventor=MACKALL%2C+Crystal&rft.inventor=JELEV%2C+Dontcho+V&rft.inventor=HEITZENEDER%2C+Sabine&rft.inventor=MARIS%2C+John&rft.inventor=BOSSE%2C+Kristopher&rft.inventor=FOSTER%2C+Jessica&rft.inventor=DIMITROV%2C+Dimiter&rft.inventor=MAJZNER%2C+Robbie&rft.inventor=ZHU%2C+ZHONGYU&rft.date=2022-08-18&rft.externalDBID=A1&rft.externalDocID=US2022257653A1